Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.860
+0.040 (1.42%)
At close: Sep 15, 2026, 4:00 PM EDT
2.889
+0.029 (1.03%)
After-hours: Sep 15, 2026, 5:23 PM EDT
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $495.19 million as of September 15, 2026. Its market cap has increased by 502.42% in one year.
Market Cap
495.19M
Enterprise Value
484.30M
1-Year Change
502.42%
Ranking
Category
Stock Price
$2.86
ChartMarket Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.40M to $495.19M, an increase of 593.54%. That is a compound annual growth rate of 26.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 495.19M | 456.39% |
| Dec 31, 2025 | 89.00M | 13.96% |
| Dec 31, 2024 | 78.10M | 351.45% |
| Dec 29, 2023 | 17.30M | -17.62% |
| Dec 30, 2022 | 21.00M | -74.07% |
| Dec 31, 2021 | 81.00M | 309.09% |
| Dec 31, 2020 | 19.80M | -23.85% |
| Dec 31, 2019 | 26.00M | -25.50% |
| Dec 31, 2018 | 34.90M | -51.12% |
| Jun 28, 2018 | 71.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 502.50M |
| Autolus Therapeutics | 500.39M |
| Artiva Biotherapeutics | 499.66M |
| Zura Bio | 499.27M |
| Capricor Therapeutics | 486.62M |
| Eikon Therapeutics | 484.24M |
| Relmada Therapeutics | 482.15M |
| ARS Pharmaceuticals | 473.37M |